Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-03-10 @ 11:38 PM
Study NCT ID:
NCT04080804
Status:
RECRUITING
Last Update Posted:
2024-12-13
First Post:
2019-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
Sponsor:
Dan Zandberg
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCC 18-139
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |